ALLMedicine™ Anticoagulation Center
Research & Reviews 427 results
https://doi.org/10.1007/s00392-021-01939-3 10.1001/jama.2020.2648 10.1001/jama.2020.1585 10.1056/NEJMoa2002032 10.1007/s11239-020-02130-7 10.1111/jth.14768 10.1038/nri3345 10.1186/s13613-017-0339-5 10.1182/blood-2018-11-882993 10.7326/M20-2003 10.1111/jth.14869 10.1097/CCM.0000000000004466 10.1016/j.jacc.2020.05.001 10.1111/jth.14817 10.1055/s-0040-1710019 10.1007/s15010-020-01499-0 10.1016/j.ejim.2020.06.006 10.2459/JCM.0000000000001066 10.1016/j.jaccas.2020.04.008 10.3390/jcm9082489 10.1016/j.thromres.2020.04.024 10.1016/j.cca.2020.04.027 10.1111/jth.14850 10.1002/ctm2.44 10.7326/M20-2003 10.1056/NEJMoa2015432 10.1182/blood.2020006520 10.1111/jth.14871 10.1016/j.ijcard.2020.12.024 10.1111/joim.13205 10.1016/j.ijcard.2020.09.001 10.1007/s00392-020-01769-9 10.1016/j.jinf.2020.07.026 10.1016/j.jacc.2016.10.060 10.1016/j.jacc.2021.02.035 10.1016/j.ijsu.2014.07.013 10.4103/sja.SJA_543_18
Clinical Research in Cardiology : Official Journal of The... Rieder M, Gauchel N et. al.
Sep 22nd, 2021 - Coagulopathy and venous thromboembolism are common findings in coronavirus disease 2019 (COVID-19) and are associated with poor outcome. Timely initiation of anticoagulation after hospital admission was shown to be beneficial. In this study we aim...
https://doi.org/10.1080/17434440.2021.1982379
Expert Review of Medical Devices; Bishay VL, Adenikinju O et. al.
Sep 18th, 2021 - Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. There has been little change in PE mortality rates over the past two decades making this an appealing area for innovation and development.Areas Covered: While anticoag...
https://doi.org/10.21037/apm-21-1693
Annals of Palliative Medicine; Chang H, Gong Y et. al.
Sep 8th, 2021 - A systematic review and meta-analysis were conducted to explore the clinical efficacy and coagulation function of regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT) in critically ill patients, to provide an effec...
https://doi.org/10.21037/apm-21-1672
Annals of Palliative Medicine; Long J, Li Z et. al.
Sep 8th, 2021 - Effective anticoagulation is a prerequisite of continuous renal replacement therapy (CRRT). During CRRT, prolonged anticoagulant therapy should be administered to prevent extracorporeal clotting. The purpose of our study was to evaluate whether a ...
https://doi.org/10.1016/j.jvir.2021.08.016
Journal of Vascular and Interventional Radiology : JVIR; Arendt VA, Mabud TS et. al.
Sep 4th, 2021 - To determine whether sub-therapeutic anticoagulation regimens are non-inferior to therapeutic anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease. Fifty-one consecutive patients (88% female, mean age...
Drugs 1 results see all →
News 49 results
https://www.medscape.com/viewarticle/952793
Jun 9th, 2021 - Three or more weeks of oral anticoagulation (OAC) sometimes isn't up to the job of clearing any potentially embolic left atrial (LA) thrombi before procedures like cardioversion or catheter ablation in patients with atrial fibrillation (AF). Such ...
https://www.medscape.com/viewarticle/949950
Apr 26th, 2021 - Some, perhaps many, previously unrecognized cases of atrial fibrillation (AF) will come to light in a screening program aimed at older asymptomatic adults. The key question is whether the challenges of such systematic but age-restricted AF screeni...
https://www.medscape.com/viewarticle/949064
Apr 9th, 2021 - Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major reg...
https://www.medscape.com/viewarticle/944133
Jan 14th, 2021 - Left atrial appendage occlusion (LAAO) for high-risk atrial fibrillation seems to prevent stroke as well as direct oral anticoagulation (DOAC) with a lower risk of major bleeding, according to results of a European study. And although some experts...
https://www.medscape.com/viewarticle/937294
Sep 11th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...
